Corbus Pharmaceuticals (CRBP) announced data from its first-in-human dose escalation clinical study conducted in the United States and the United Kingdom of CRB-701 will be presented at the 2025 American Society of Clinical Oncology Genitourinary Cancers Symposium, to be held in San Francisco, CA February 13-15, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRBP: